First experiences with a novel magnetically suspended axial flow left ventricular assist device.

Abstract

UNLABELLED Axial flow pumps have gained increased acceptance since their first clinical use in 1998. The present report summarizes the clinical experience with patients treated for severe cardiogenic shock for the first time with a newly developed axial flow pump with magnetically levitated bearings. MATERIAL AND METHODS The axial flow pump Incor was implanted in 24 patients between June 2002 and June 2003. All except one patient were men. In 16 patients dilative cardiomyopathy, in seven ischemic and in one restrictive cardiomypathy had been diagnosed. All patients presented with catecholamine-dependent end-stage heart failure, seven of them were on an artificial ventilator and three were dependent on intraaortic balloon pump support. All patients suffered from organ dysfunction resulting from low cardiac output. RESULTS There were no perioperative deaths. The 30-day mortality rate was 8% (n = 2); 79% ( n = 19) of patients reached a condition to be discharged home. The cumulative time on the device is 6.9 years; the longest individual time up to July 1, 2003 is 12.6 months. There were no structural defects or failures of the system. In one case the controller had to be exchanged because of intermittent malfunction. Cardiac output ranged between 4 and 6 l in all instances and there were no cases of infection of the drive-line or the system. Hemolysis was present initially but was not detectable in the later course. There were three instances of transient ischemic attacks. Two patients developed late cardiac tamponade with re-opening of the chest after 9 and 14 days. In one patient persistent gastrointestinal bleeding required re-hospitalization and transfusion therapy. Two patients were weaned from the device after 6 and 7 months of support, respectively. CONCLUSION The preliminary clinical experience with Incor is promising. The flow is sufficient for recovery from multiorgan failure and the pump allows long-term hemolysis-free support. The concept of magnetically levitated bearings has proven to be durable and reliable. In the case that the heart may recover through unloading, weaning from the pump is possible.

7 Figures and Tables

Statistics

020406080'04'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

132 Citations

Semantic Scholar estimates that this publication has 132 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Hetzer2004FirstEW, title={First experiences with a novel magnetically suspended axial flow left ventricular assist device.}, author={Roland Hetzer and Yuguo Weng and Evgenij V. Potapov and Miralem Pasi{\'c} and Thorsten N H Drews and Michael J. Jurmann and Ewald Hennig and Johannes M{\"{u}ller}, journal={European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery}, year={2004}, volume={25 6}, pages={964-70} }